TASK DEFINITION: Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.
PROBLEM: Paragraph: The company earned $728 million, or 67 cents per share, in the fourth quarter. That compared with $827 million, or 74 cents per share, in the year-earlier quarter, when Lilly took charges for asset impairments and restructuring. "Company sales were stronger than thought, but a lot of that upside came from drugs that are already off patent or about to lose patent protection," said Edward Jones analyst Judson Clark. Excluding special items, Lilly earned 74 cents per share, matching analysts' average forecasts, according to Thomson Reuters I/B/E/S. Shares in the company dropped 1.4 percent to 53.21, after earlier reaching their lowest in two weeks at $53.05. Lilly's global sales fell 2 percent to $5.81 billion, but topped Wall Street forecasts of $5.46 billion. Sales would have been flat if not for the stronger dollar, which lowers the value of sales in overseas markets. Sales of Cymbalta, which lost U.S. patent protection last month, fell 38 percent to $883 million. But they came in about $100 million higher than Wall Street expected, analysts said. Lilly's sales, earnings, and its share price, have been badly hurt since late 2011, when its Zyprexa schizophrenia drug lost U.S. patent protection. Once Lilly's biggest product, with annual sales of $5 billion, it now has sales of only $1.5 billion. The situation worsened last month, when Cymbalta - which also had $5 billion in annual sales at its peak - began facing cheaper generics in the United States. The company's "patent cliff" will become more daunting in March, when $1 billion-a-year osteoporosis drug Evista faces U.S. generics. "We haven't wasted the crisis," Chief Executive John Lechleiter said Thursday in a conference call with industry analysts. "We're more agile, we're leaner and I believe we're better operators today." Lilly has cut more than 5,000 employees from its workforce in order to reduce annual costs by $1 billion over the last three years to deal with patent expirations on its drugs. It has also restructured itself to focus on cancer and diabetes - lucrative specialties that are two of the company's longstanding strengths. Clark said sales of Cymbalta could eventually decline 80 percent, which has been the case for many other blockbuster medicines in recent years. He questioned whether gains for other products seen in the fourth quarter will be sustainable. Sales of many products over the quarter showed double-digit sales increases, including Lilly's Humalog insulin, Cialis anti-impotence treatment, Forteo and Evista osteoporosis drugs, and Straterra for attention deficit disorder. But price increases in the United States accounted for much of those sales gains. The Indianapolis drugmaker is expecting a return to company sales growth next year, from increased sales of drugs that still have patent protection and from launches of new treatments for cancer and diabetes. It hopes to launch three new drugs this year: ramucirumab for stomach cancer, and dulaglutide and empagliflozin for type 2 diabetes - the most common form of the disease, which is closely linked to obesity. Although analysts have forecast annual sales of more than $650 million for ramucirumab, they are concerned the new diabetes drugs may have a hard time competing with similar drugs already on the market. The company has introduced no new products in recent years. In a recent interview, Lechleiter said it was time for Lilly "to go back on offense", helped by a pipeline of nearly 40 medicines in mid- and late-stage studies, compared with only seven in those stages of development a decade ago. Claim: Lilly's quarterly sales largely offset Cymbalta slide.

SOLUTION: Drugmaker Eli Lilly and Co's quarterly revenue fell far less than expected, it reported on Thursday, as plunging sales of its Cymbalta depression treatment were largely offset by higher revenues for most of its other prescription drugs.

PROBLEM: Paragraph: Sometime before Oct. 1, the state will start using electronic benefits transfer cards that will allow recipients on the Women, Infants and Children program to buy food at grocery stores and pharmacies Most states are already doing that, and Mississippi is among the few still using a warehouse distribution system, the Commercial Dispatch reported. WIC provides "nutritious foods to supplement diets, information on healthy eating including breastfeeding promotion and support, and referrals to health care" to low-income pregnant, postpartum and breastfeeding women, infants and children up to age 5 who are considered to be at nutritional risk, according to the U.S. Department of Agriculture. The program serves almost half of all infants born in the United States. WIC foods include "infant cereal, iron-fortified adult cereal, vitamin C-rich fruit or vegetable juice, eggs, milk, cheese, peanut butter, dried and canned beans/peas, and canned fish." Katie Peterson, a mother of two young children, picked up packages of food recently at the WIC warehouse in Oktibbeha County. "I don't have a lot of free time, so coming down here can be kind of difficult at times," Peterson said. "They often run out of stuff too, so when I'm here, I'll have to skip a couple things that are on my list." Peterson said picking up WIC-approved food at a grocery store "would be wonderful." Each state's health department operates the WIC program, with funding and guidelines from the USDA. The federal agency decided all 50 states must start using electronic cards for WIC recipients by Oct. 1. Each county in Mississippi has at least one WIC warehouse. Liz Sharlot, spokeswoman for the Mississippi State Department of Health, said there will be no need for WIC warehouses once the cards are in place. Oktibbeha County resident Mariam Reynolds, a mother of three, said she got WIC products from grocery stores when she lived in Birmingham, Alabama. "You can go to the grocery store any time to get what you need, and you've probably got better options," Reynolds said. Selection and availability were not a problem for Peterson and her family when they lived in Illinois, which administers its WIC program at grocery stores, she said. "If I need milk and eggs, and they don't have eggs (at the warehouse), I either have to get the milk and skip the eggs or just get nothing at all," Peterson said. WIC's transition from warehouses to grocery stores is still in the early stages of searching for and authorizing grocery stores and pharmacies as vendors, so nothing is final yet, but "the wheels are in motion," Sharlot said. Claim: Mississippi will phase out warehouses for nutrition program.

SOLUTION: Mississippi will close distribution centers for a federal nutrition program in the coming year and will move to a system that could be simpler to use.

PROBLEM: Paragraph: The University Hospital in the second-largest Czech city of Brno said Tuesday the 2.1-kilogram (4.6-pound) baby was born by cesarean section when the mother was 34 weeks pregnant. The hospital statement did not provide details on the baby's health, but Czech public television said the girl born earlier this month is now with her father. The 27-year-old mother was declared brain-dead in early June after suffering a brain hemorrhage a few weeks into her pregnancy. At the time, the hospital said doctors would keep the mother alive on mechanical support until the baby was developed enough to be delivered. Claim: Czech hospital says baby girl born to brain-dead mother.

SOLUTION:
A Czech clinic says a baby girl has been born to a brain-dead woman kept on life support for nearly three months to allow her pregnancy to go ahead.